Shares of JD.com (NASDAQ: JD) gained for the second day in a row Thursday after it posted a strong first-quarter earnings report on Wednesday morning. The stock continued its rise as a number of analysts reaffirmed their buy ratings, growth stocks gained broadly, and JD.com's health division announced a new partnership in cancer management.
The stock closed the session up 4.4%.
Image source: JD.com
Source Fool.com